🇺🇸 FDA
Patent

US 9827241

Injectable flowable composition comprising buprenorphine

granted A61KA61K31/00A61K31/4748

Quick answer

US patent 9827241 (Injectable flowable composition comprising buprenorphine) held by Indivior UK Limited expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K31/00, A61K31/4748, A61K31/485, A61K47/22